These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6236326

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
    Seki M, Ohi H, Watanabe S, Kojima H, Fujita T, Hatano M.
    Nihon Jinzo Gakkai Shi; 1987 May; 29(5):585-8. PubMed ID: 3656714
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M.
    Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
    [Abstract] [Full Text] [Related]

  • 8. Anti-Factor B Antibodies and Acute Postinfectious GN in Children.
    Chauvet S, Berthaud R, Devriese M, Mignotet M, Vieira Martins P, Robe-Rybkine T, Miteva MA, Gyulkhandanyan A, Ryckewaert A, Louillet F, Merieau E, Mestrallet G, Rousset-Rouvière C, Thervet E, Hogan J, Ulinski T, Villoutreix BO, Roumenina L, Boyer O, Frémeaux-Bacchi V.
    J Am Soc Nephrol; 2020 Apr; 31(4):829-840. PubMed ID: 32034108
    [Abstract] [Full Text] [Related]

  • 9. Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.
    Corvillo F, Bravo García-Morato M, Nozal P, Garrido S, Tortajada A, Rodríguez de Córdoba S, López-Trascasa M.
    Clin Exp Immunol; 2016 Apr; 184(1):118-25. PubMed ID: 26660535
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases.
    Michels MAHM, van de Kar NCAJ, Okrój M, Blom AM, van Kraaij SAW, Volokhina EB, van den Heuvel LPWJ.
    Front Immunol; 2018 Apr; 9():612. PubMed ID: 29670616
    [Abstract] [Full Text] [Related]

  • 16. Hypocomplementemic and normocomplementemic acute nephritis in children: a comparison with respect to etiology, clinical manifestations, and glomerular morphology.
    Strife CF, McAdams AJ, McEnery PT, Bove KE, West CD.
    J Pediatr; 1974 Jan; 84(1):29-38. PubMed ID: 12119953
    [Abstract] [Full Text] [Related]

  • 17. A hemolytic method for the measurement of nephritic factor.
    West CD.
    J Immunol Methods; 2008 Jun 01; 335(1-2):1-7. PubMed ID: 18410942
    [Abstract] [Full Text] [Related]

  • 18. Deposition of beta 1H globulin in kidneys of patients with immune renal disease.
    Carlo JR, Ruddy S, Sauter S, Yount WJ.
    Arthritis Rheum; 1979 Apr 01; 22(4):403-11. PubMed ID: 85452
    [Abstract] [Full Text] [Related]

  • 19. Circulating complement levels and C3 glomerulopathy.
    Fervenza FC, Sethi S.
    Clin J Am Soc Nephrol; 2014 Nov 07; 9(11):1829-31. PubMed ID: 25341723
    [No Abstract] [Full Text] [Related]

  • 20. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
    Craddock CF, Richards NP, Powell RJ, Morgan AG.
    Q J Med; 1987 Nov 07; 65(247):895-8. PubMed ID: 3455546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.